Download PDF
CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2020; 24(02): e221-e226
DOI: 10.1055/s-0039-1698784
Original Research
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Malignancy Rate in Thyroid Nodules with Atypia or Follicular Lesion of Undetermined Significance

Hamdan Ahmed Pasha 
1   Department of Surgery, Section of Otolaryngology/Head and Neck Surgery, Aga Khan University, Karachi, Pakistan
,
Rahim Dhanani
1   Department of Surgery, Section of Otolaryngology/Head and Neck Surgery, Aga Khan University, Karachi, Pakistan
,
Ainulakbar Mughal
1   Department of Surgery, Section of Otolaryngology/Head and Neck Surgery, Aga Khan University, Karachi, Pakistan
,
Kaleem S. Ahmed
1   Department of Surgery, Section of Otolaryngology/Head and Neck Surgery, Aga Khan University, Karachi, Pakistan
,
Anwar Suhail
1   Department of Surgery, Section of Otolaryngology/Head and Neck Surgery, Aga Khan University, Karachi, Pakistan
› Author Affiliations
Further Information

Publication History

06 January 2019

07 September 2019

Publication Date:
28 January 2020 (online)

   Permissions and Reprints

Abstract

Introduction Atypia of undetermined significance (AUS) or follicular lesion of undetermined significance (FLUS) is one of the six diagnostic categories of the Bethesda System for Reporting Thyroid Cytopathology. The prevalence of malignancy among Bethesda category III cytology is variable, ranging from 5% to 37% in the literature.

Objective To determine the rate of malignancy in thyroid nodules reported as Bethesda category III.

Methods A total of 495 patients underwent surgical intervention for thyroid nodules from January 2015 to December 2017. The present study included 81 cases reported as Bethesda category III, and their medical records were reviewed.

Results Out of 495 fine-needle aspiration cytology samples, 81 (16.4%) samples were labeled as AUS/FLUS. Among these 81 patients, the mean age was 43.0 years (± 13.9), with only 11 (14%) patients older than 55 years of age. Most of our patients were female (n = 69; 85.2%), and the rest were male. The rate of malignancy based on the final histology was of 33.3% (n = 27). The majority were 17 cases (21%) of papillary carcinoma, followed by follicular carcinoma (n = 6) (7.4%).

Conclusion The risk of malignancy can be higher than it is commonly believed, and guidelines should be based on the data from the institutions themselves for a better assessment of the outcomes.

Keywords

atypia of undetermined significance - thyroid nodule - bethesda - fine-needle aspiration

Presentation

The abstract was presented at 10th International Academic Conference in Otology, Rhinology and Laryngology (ORLIAC 2018), which was held from March 1st to 3rd, 2018 at Makati, the Philippines.


 

  • References

  • 1 Cooper DS, Doherty GM, Haugen BR. , et al; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19 (11) 1167-1214
    CrossrefPubMedGoogle Scholar
  • 2 Cibas ES, Ali SZ. ; NCI Thyroid FNA State of the Science Conference. The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol 2009; 132 (05) 658-665
    CrossrefPubMedGoogle Scholar
  • 3 Cross PA, Poller D. The Bethesda thyroid terminology and progress towards international agreement on thyroid FNA cytology reporting. Cytopathology 2010; 21 (02) 71-74
    CrossrefPubMedGoogle Scholar
  • 4 Crippa S, Mazzucchelli L, Cibas ES, Ali SZ. The Bethesda System for reporting thyroid fine-needle aspiration specimens. Am J Clin Pathol 2010; 134 (02) 343-344 , author reply 345
    CrossrefPubMedGoogle Scholar
  • 5 Ohori NP, Schoedel KE. Variability in the atypia of undetermined significance/follicular lesion of undetermined significance diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: sources and recommendations. Acta Cytol 2011; 55 (06) 492-498
    CrossrefPubMedGoogle Scholar
  • 6 Song JY, Chu YC, Kim L, Park IS, Han JY, Kim JM. Reclassifying formerly indeterminate thyroid FNAs using the Bethesda system reduces the number of inconclusive cases. Acta Cytol 2012; 56 (02) 122-129
    CrossrefPubMedGoogle Scholar
  • 7 Seagrove-Guffey MA, Hatic H, Peng H, Bates KC, Odugbesan AO. Malignancy rate of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid nodules undergoing FNA in a suburban endocrinology practice: A retrospective cohort analysis. Cancer Cytopathol 2018; 126 (10) 881-888
    Google Scholar
  • 8 Méndez W, Rodgers SE, Lew JI, Montano R, Solórzano CC. Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules. Ann Surg Oncol 2008; 15 (09) 2487-2492
    CrossrefPubMedGoogle Scholar
  • 9 Horne MJ, Chhieng DC, Theoharis C. , et al. Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification. Diagn Cytopathol 2012; 40 (05) 410-415
    CrossrefPubMedGoogle Scholar
  • 10 Akın Ş. Atypia of Undetermined Significance on Thyroid Fine Needle Aspiration Cytology: Pathological Evaluation and Risk Factors for Malignancy. South Clin Istanb Eurasia [Internet]. 2017 [cited 2019 Jul 30]; Available from: http://scie.online/jvi.aspx?un=KEAH-54926
    PubMedGoogle Scholar
  • 11 Hong S-H, Lee H, Cho M-S, Lee JE, Sung Y-A, Hong YS. Malignancy Risk and Related Factors of Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance in Thyroid Fine Needle Aspiration. Int J Endocrinol 2018; 2018: 4521984
    PubMedGoogle Scholar
  • 12 López Vázquez Y, Penín Álvarez M, San Miguel Fraile P, Barragáns Pérez M. Riesgo de malignidad de los nódulos tiroideos con atipia de significado incierto. Endocrinol Nutr 2015; 62 (10) 507-510
    CrossrefPubMedGoogle Scholar
  • 13 Luu MH, Fischer AH, Stockl TJ, Pisharodi L, Owens CL. Atypical follicular cells with equivocal features of papillary thyroid carcinoma is not a low-risk cytologic diagnosis. Acta Cytol 2011; 55 (06) 526-530
    CrossrefPubMedGoogle Scholar
  • 14 Kim SJ, Roh J, Baek JH. , et al. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology. Cytopathology 2017; 28 (01) 65-73
    CrossrefPubMedGoogle Scholar
  • 15 Eisa N, Khan A, Akhter M. , et al. Both Ultrasound Features and Nuclear Atypia are Associated with Malignancy in Thyroid Nodules with Atypia of Undetermined Significance. Ann Surg Oncol 2018; 25 (13) 3913-3918
    CrossrefPubMedGoogle Scholar
  • 16 Seo JW, Jang AL, Suh SH, Park HS, Kang MK, Hong JC. Atypia of undetermined significance on thyroid fine needle aspiration - risk factors for malignancy. Clin Otolaryngol 2017; 42 (02) 234-238
    CrossrefPubMedGoogle Scholar
  • 17 Sullivan PS, Hirschowitz SL, Fung PC, Apple SK. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System. Cancer Cytopathol 2014; 122 (12) 866-872
    Google Scholar
  • 18 Gweon HM, Son EJ, Youk JH, Kim J-A. Thyroid nodules with Bethesda system III cytology: can ultrasonography guide the next step?. Ann Surg Oncol 2013; 20 (09) 3083-3088
    CrossrefPubMedGoogle Scholar
  • 19 Maia FFR, Matos PS, Pavin EJ, Zantut-Wittmann DE. Thyroid imaging reporting and data system score combined with Bethesda system for malignancy risk stratification in thyroid nodules with indeterminate results on cytology. Clin Endocrinol (Oxf) 2015; 82 (03) 439-444
    CrossrefPubMedGoogle Scholar
  • 20 Bongiovanni M, Piana S, Spitale A, Valli R, Carlinfante G, Gardini G. Comparison of the diagnostic accuracy of thyroid fine-needle aspiration in follicular-patterned lesions using a 5-tiered and a 6-tiered diagnostic system: a double-blind study of 140 cases with histological confirmation. Diagn Cytopathol 2014; 42 (09) 744-750
    CrossrefPubMedGoogle Scholar
  • 21 Raparia K, Min SK, Mody DR, Anton R, Amrikachi M. Clinical outcomes for “suspicious” category in thyroid fine-needle aspiration biopsy: Patient's sex and nodule size are possible predictors of malignancy. Arch Pathol Lab Med 2009; 133 (05) 787-790
    CrossrefPubMedGoogle Scholar
  • 22 Harvey AM, Mody DR, Amrikachi M. Thyroid fine-needle aspiration reporting rates and outcomes before and after Bethesda implementation within a combined academic and community hospital system. Arch Pathol Lab Med 2013; 137 (11) 1664-1668
    CrossrefPubMedGoogle Scholar
  • 23 Rabaglia JL, Kabbani W, Wallace L. , et al. Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery 2010; 148 (06) 1267-1272 , discussion 1272–1273
    CrossrefPubMedGoogle Scholar
  • 24 Shi Y, Ding X, Klein M. , et al. Thyroid fine-needle aspiration with atypia of undetermined significance: a necessary or optional category?. Cancer 2009; 117 (05) 298-304
    PubMedGoogle Scholar
  • 25 Broome JT, Solorzano CC. The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda System for Reporting Thyroid Cytopathology. Surgery 2011; 150 (06) 1234-1241
    CrossrefPubMedGoogle Scholar
  • 26 Bernstein JM, Shah M, MacMillan C, Freeman JL. Institution-specific risk of papillary thyroid carcinoma in atypia/follicular lesion of undetermined significance. Head Neck 2016; 38 (Suppl. 01) E1210-E1215
    CrossrefPubMedGoogle Scholar
  • 27 Kholová I, Ludvíková M. Thyroid atypia of undetermined significance or follicular lesion of undetermined significance: an indispensable Bethesda 2010 diagnostic category or waste garbage?. Acta Cytol 2014; 58 (04) 319-329
    CrossrefPubMedGoogle Scholar
  • 28 Kennedy JM, Robinson RA. Thyroid Frozen Sections in Patients With Preoperative FNAs: Review of Surgeons' Preoperative Rationale, Intraoperative Decisions, and Final Outcome. Am J Clin Pathol 2016; 145 (05) 660-665
    CrossrefPubMedGoogle Scholar
  • 29 Kahmke R, Lee WT, Puscas L. , et al. Utility of Intraoperative Frozen Sections during Thyroid Surgery. Int J Otolaryngol 2013; 2013: 496138
    PubMedGoogle Scholar
  • 30 Cohen MA, Patel KR, Gromis J. , et al. Retrospective evaluation of frozen section use for thyroid nodules with a prior fine needle aspiration diagnosis of Bethesda II-VI: The Weill Cornell Medical College experience. World J Otorhinolaryngol Head Neck Surg 2015; 1 (01) 5-10
    PubMedGoogle Scholar
  • 31 Berg RW, Yen TW, Evans DB. , et al. Analysis of an institutional protocol for thyroid lobectomy: Utility of routine intraoperative frozen section and expedited (overnight) pathology. Surgery 2016; 159 (02) 512-517
    CrossrefPubMedGoogle Scholar
  • 32 Mayooran N, Waters PS, Kaim Khani TY, Kerin MJ, Quill D. FNAC and frozen section correlations with definitive histology in thyroid diseases. Eur Arch Otorhinolaryngol. 2016; 273 (08) 2181-2184
    PubMedGoogle Scholar
  • 33 Najah H, Tresallet C. Role of frozen section in the surgical management of indeterminate thyroid nodules. Gland Surg [Internet]. 2019 Apr 19 [cited 2019 Jul 30];0(0). Available from: http://gs.amegroups.com/article/view/25191
    PubMedGoogle Scholar
  • 34 Ho AS, Sarti EE, Jain KS. , et al. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid 2014; 24 (05) 832-839
    CrossrefPubMedGoogle Scholar
  • 35 Jan I-S, Lee Y-T, Wang C-M. , et al. The surgery and repeat aspiration outcomes of the atypia of undetermined significance/follicular lesion of undetermined significance category in The Bethesda System for Reporting Thyroid Cytopathology. Asian J Surg 2019; 42 (01) 144-147
    CrossrefPubMedGoogle Scholar
  • 36 Straccia P, Rossi ED, Bizzarro T. , et al. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?. Cancer Cytopathol 2015; 123 (12) 713-722
    Google Scholar
  • 37 Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2017; 27 (11) 1341-1346
    CrossrefPubMedGoogle Scholar